High Tone Power Therapy on Lumbosacral Radiculopathy Patients
Effect of High Tone Power Therapy on Pain, Range of Motion and Quality of Life in Lumbosacral Radiculopathy Patients
1 other identifier
interventional
52
1 country
1
Brief Summary
to investigate the effect of High Tone Power Therapy on Pain, Range of Motion and Quality of Life in Lumbosacral Radiculopathy Patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 12, 2025
CompletedStudy Start
First participant enrolled
December 15, 2025
CompletedFirst Posted
Study publicly available on registry
December 26, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2026
CompletedApril 8, 2026
April 1, 2026
2 months
December 12, 2025
April 2, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Pain Pressure Threshold Algometer
An algometer is a device used with pressure algometry to measure the pain pressure threshold (PPT), which is the point at which a steadily increasing, non-painful pressure stimulus is perceived as painful.
four weeks
Back range of motion (BROM) goniometer device
is a specialized instrument, often using inclinometers and magnets, that provides accurate and repeatable measurements of spinal movements such as flexion, extension, rotation, and lateral side bend
four weeks
Short Form Health Survey (SF-36)
The the SF-36, is a 36-item questionnaire developed by the RAND Corporation to measure health-related quality of life across eight domains: physical functioning, bodily pain, role limitations (due to physical or emotional problems), social functioning, emotional well-being, vitality (energy/fatigue), and general health. It also includes an additional item to assess self-perceived health changes over time. A score range from 0 to 100. high scores indicate more quality of life
four weeks
Secondary Outcomes (1)
Visual analogue scale for pain (VAS-P)
four weeks
Study Arms (2)
study group High tone power therapy
EXPERIMENTALStudy group : received the selected physical therapy program in addition to High tone power therapy.
control group traditional therapy
EXPERIMENTALreceived receive a selected physical therapy program only (Therapeutic Ultrasound device, Hot packs and Neurodynamic mobilization for sciatic nerve
Interventions
selected physical therapy program including (Therapeutic Ultrasound device, Hot packs and Neurodynamic mobilization for sciatic nerve
High Tone Power Therapy (HiToP), or High-Frequency External Muscle Stimulation (HTEMS), is an advanced form of electrotherapy that uses medium-frequency sinusoidal currents with simultaneously modulated amplitude and frequency to treat various conditions, especially neurological symptoms and pain
Eligibility Criteria
You may qualify if:
- Their ages range from 35 to 50 years.
- Both sex.
- Back pain for more than six months; radiating unilaterally down to one lower limb over the dermatomal distributions of L4-L5, L5-S1 nerve roots.
- Radiological confirmation of disc herniation or protrusion at L4-5 or L5-S1 levels by MRI.
- Symptom duration of at least 4 weeks and not more than 6 months.
- Positive Straight Leg Raise test
- Body mass index (18.5 - 24.99Kg/m2).
You may not qualify if:
- Red flags: spinal tumors, cauda equina syndrome, spinal fractures, osteoporosis, infection.
- Bilateral symptoms.
- Spondylolisthesis, spondylitis, spinal canal stenosis.
- Previous lumbopelvic or hip surgery or injection.
- Any hip structural abnormality such as malformations, impingements and degeneration.
- Postural deviations such as scoliosis, kyphosis and lateral shift.
- Fibromyalgia.
- Pregnancy and Gynecological problems.
- Systemic inflammatory conditions (e.g., rheumatoid arthritis and ankylosing spondylitis)
- Uncontrolled chronic conditions (e.g., diabetes mellitus with neuropathy and severe cardiovascular disease)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
October 6 University
Giza, El-Sheikh Zayed City Giza 1133 Egypt, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Lama Saad ED Mahmoud
October 6 University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Neurology and Neurosurgery Faculty of Physical Therapy October 6 University
Study Record Dates
First Submitted
December 12, 2025
First Posted
December 26, 2025
Study Start
December 15, 2025
Primary Completion
January 30, 2026
Study Completion
January 30, 2026
Last Updated
April 8, 2026
Record last verified: 2026-04